Treatment of HIV-infected fibroblasts with human leukocyte antigen (HLA)-DR-inductive cytokines leads to infectious virions with newly acquired HLA-DR.
Capobianchi
M R
MR
Serra
C
C
Abbate
I
I
Marongiu
P
P
Castilletti
C
C
Tilocca
F
F
Dianzani
F
F
Dolei
A
A
D002352:Carrier Proteins / Q000378:metabolism; D002460:Cell Line; D016207:Cytokines / Q000494:pharmacology; D005347:Fibroblasts / Q000276:immunology / Q000821:virology; D015658:HIV Infections / Q000276:immunology* / Q000821:virology; D015497:HIV-1 / Q000276:immunology*; D006684:HLA-DR Antigens / Q000096:biosynthesis*; D006801:Humans; D018960:Hyaluronan Receptors; D066298:In Vitro Techniques; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D016201:Receptors, Lymphocyte Homing / Q000378:metabolism
D002352:Carrier Proteins; D016207:Cytokines; D006684:HLA-DR Antigens; D018960:Hyaluronan Receptors; D011956:Receptors, Cell Surface; D016201:Receptors, Lymphocyte Homing; D018799:Intercellular Adhesion Molecule-1